Review
World J Diabetes
10(8):421-445.
Published online Aug 15, 2019.
doi: 10.4239/wjd.v10.i8.421
Abstract (1512)
|
Core Tip (1384)
|
Full Article (HTML) (8769)
|
Figures (1-1) (1235)
|
Tables (1-2) (710)
|
Full Article (PDF)-1341K (1090)
|
Audio-1919K (10)
|
Peer-Review Report-143K (348)
|
Answering Reviewers-93K (355)
|
Received: 04/04/2019
|
Revised: 06/03/2019
|
Accepted: 07/20/2019
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (70)
|
Total Visits (20903)
|
Similar Articles (35)
|
Timeline of Article Publication (11)
|
Authors Evaluation (7)
|
Article Quality Tracking (2)
|
Cite
|
(0)
|
(0)
|
Open
Minireviews
Development of therapeutic options on type 2 diabetes in years: Glucagon-like peptide-1 receptor agonist’s role intreatment; from the past to future
World J Diabetes
10(8):446-453.
Published online Aug 15, 2019.
doi: 10.4239/wjd.v10.i8.446
Abstract (1251)
|
Core Tip (1216)
|
Full Article (HTML) (4563)
|
Tables (1-2) (566)
|
Full Article (PDF)-705K (696)
|
Audio-761K (19)
|
Peer-Review Report-203K (344)
|
Answering Reviewers-108K (297)
|
Received: 03/21/2019
|
Revised: 06/13/2019
|
Accepted: 07/27/2019
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (21)
|
Total Visits (13495)
|
Similar Articles (1)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
Cite
|
(0)
|
(0)
|
Open
World J Diabetes
10(8):454-462.
Published online Aug 15, 2019.
doi: 10.4239/wjd.v10.i8.454
Abstract (1183)
|
Core Tip (1030)
|
Full Article (HTML) (4557)
|
Tables (1-1) (1082)
|
Full Article (PDF)-679K (667)
|
Peer-Review Report-138K (239)
|
Answering Reviewers-10K (312)
|
Received: 02/20/2019
|
Revised: 07/05/2019
|
Accepted: 07/20/2019
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (17534)
|
Similar Articles (6)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (1)
|
Cite
|
(0)
|
(0)
|
Open
Retrospective Study
Comparison of awareness of diabetes mellitus type II with treatment’s outcome in term of direct cost in a hospital in Saudi Arabia
World J Diabetes
10(8):463-472.
Published online Aug 15, 2019.
doi: 10.4239/wjd.v10.i8.463
Abstract (1328)
|
Core Tip (1279)
|
Article Highlights (1286)
|
Full Article (HTML) (4711)
|
Tables (1-1) (550)
|
Full Article (PDF)-708K (453)
|
Audio-322K (17)
|
Peer-Review Report-148K (420)
|
Answering Reviewers-74K (284)
|
Received: 05/01/2019
|
Revised: 06/08/2019
|
Accepted: 07/20/2019
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (17822)
|
Similar Articles (248)
|
Timeline of Article Publication (3)
|
Authors Evaluation (3)
|
Article Quality Tracking (1)
|
Cite
|
(0)
|
(0)
|
Open